Edgewise 治療公司
US ˙ NasdaqGS ˙ US28036F1057

SecurityEWTX / Edgewise Therapeutics, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership41,726 shares
Latest Disclosed Value $ 1,314,370
Franklin Resources Inc reports 3.29% decrease in ownership of EWTX / Edgewise Therapeutics, Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 41,726 shares of Edgewise Therapeutics, Inc. (US:EWTX) valued at $1,314,369 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 43,145 shares of Edgewise Therapeutics, Inc.. This represents a change in shares of -3.29% during the quarter. The current value of the position is $1,553,459 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F EDGEWISE THERAPEUTICS COM 28036F105 41,726 -1,419 -3.29 1,314 22.80 0.0001
2026-02-11 2025-12-31 13F EDGEWISE THERAPEUTICS COM 28036F105 43,145 -5,075 -10.52 1,071 36.83 0.0003
2025-11-13 2025-09-30 13F EDGEWISE THERAPEUTICS COM 28036F105 48,220 2,414 5.27 782 30.33 0.0002
2025-08-12 2025-06-30 13F EDGEWISE THERAPEUTICS COM 28036F105 45,806 -481 -1.04 601 -41.06 0.0002
2025-05-13 2025-03-31 13F EDGEWISE THERAPEUTICS COM 28036F105 46,287 14,680 46.45 1,018 20.76 0.0003
2025-02-12 2024-12-31 13F EDGEWISE THERAPEUTICS COM 28036F105 31,607 -13,616 -30.11 844 -41.38 0.0002
2024-11-27 2024-09-30 13F/A-1 EDGEWISE THERAPEUTICS COM 28036F105 45,223 20,674 84.22 1,439 225.34 0.0004
2024-11-12 2024-09-30 13F EDGEWISE THERAPEUTICS COM 28036F105 45,223 20,674 1,439 0.0001
2024-08-14 2024-06-30 13F EDGEWISE THERAPEUTICS COM 28036F105 24,549 4,544 22.71 442 21.43 0.0001
2024-05-13 2024-03-31 13F EDGEWISE THERAPEUTICS COM 28036F105 20,005 20,005 365 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.